Pharvaris Company Insiders
| PHVS Stock | USD 21.90 0.46 2.06% |
Pharvaris employs about 83 people. The company is managed by 12 executives with a total tenure of roughly 194 years, averaging almost 16.0 years of service per executive, having 6.92 employees per reported executive. Breaking down Pharvaris' management performance can provide insight into the firm performance.
Pharvaris |
Pharvaris Management Team Effectiveness
The company has return on total asset (ROA) of (0.2679) % which means that it has lost $0.2679 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4505) %, meaning that it created substantial loss on money invested by shareholders. Pharvaris' management efficiency ratios could be used to measure how well Pharvaris manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.27 in 2024. Return On Capital Employed is likely to drop to -0.26 in 2024. At this time, Pharvaris' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 885.3 K in 2024, whereas Return On Tangible Assets are likely to drop (0.27) in 2024.Common Stock Shares Outstanding is likely to drop to about 31.4 M in 2024. Net Loss is likely to gain to about (65.3 M) in 2024
Pharvaris Workforce Comparison
Pharvaris BV is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,022. Pharvaris holds roughly 83.0 in number of employees claiming about 8% of equities under Health Care industry.
Pharvaris BV Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharvaris BV Price Series Summation is a cross summation of Pharvaris price series and its benchmark/peer.
Pharvaris Notable Stakeholders
A Pharvaris stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pharvaris often face trade-offs trying to please all of them. Pharvaris' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pharvaris' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David JD | CFO Secretary | Profile | |
| Peng MD | Chief Officer | Profile | |
| Morgan Conn | Chief Officer | Profile | |
| Jochen Knolle | Chief COO | Profile | |
| CPA MBA | CEO CoFounder | Profile | |
| Joan JD | Chief Officer | Profile | |
| Stefan Abele | Chief Officer | Profile | |
| Wim Souverijns | Chief Officer | Profile | |
| Anne Lesage | Chief Officer | Profile | |
| RA MSc | Head Officer | Profile | |
| Maryann Cimino | Director Relations | Profile | |
| Annick Deschoolmeester | Chief Officer | Profile |
About Pharvaris Management Performance
The success or failure of an entity such as Pharvaris BV often depends on how effective the management is. Pharvaris management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharvaris management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharvaris management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.27) | |
| Return On Capital Employed | (0.25) | (0.26) | |
| Return On Assets | (0.25) | (0.27) | |
| Return On Equity | (0.26) | (0.28) |
Please note, the imprecision that can be found in Pharvaris' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pharvaris BV. Check Pharvaris' Beneish M Score to see the likelihood of Pharvaris' management manipulating its earnings.
Pharvaris Workforce Analysis
Traditionally, organizations such as Pharvaris use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharvaris within its industry.Pharvaris Manpower Efficiency
Return on Pharvaris Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.2M | |
| Net Loss Per Executive | 8.3M | |
| Working Capital Per Employee | 4.6M | |
| Working Capital Per Executive | 31.9M |
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.